New insight into the treatment of advanced differentiated thyroid cancer
A Safavi, A Vijayasekaran… - Journal of thyroid …, 2012 - Wiley Online Library
The vast majority of patients with differentiated thyroid cancer (DTC) are treated successfully
with surgery and radioactive iodine ablation, yet the treatment of advanced cases is …
with surgery and radioactive iodine ablation, yet the treatment of advanced cases is …
Update on the molecular diagnosis and targeted therapy of thyroid cancer
M Liu, M Ruan, L Chen - Medical oncology, 2014 - Springer
Thyroid cancer (TC) is the most common endocrine malignancy with steadily increasing
incidence over the past few decades. Although standard strategies for the management of …
incidence over the past few decades. Although standard strategies for the management of …
An update on molecular biology of thyroid cancers
O Omur, Y Baran - Critical reviews in oncology/hematology, 2014 - Elsevier
Differentiated thyroid cancer (DTC) is the most common endocrinological malignancy. There
are several histological variants such as papillary and follicular thyroid carcinoma. Many …
are several histological variants such as papillary and follicular thyroid carcinoma. Many …
Molecular targeted therapies of aggressive thyroid cancer
SM Ferrari, P Fallahi, U Politti, G Materazzi… - Frontiers in …, 2015 - frontiersin.org
Differentiated thyroid carcinomas (DTCs) that arise from follicular cells account> 90% of
thyroid cancer (TC)[papillary thyroid cancer (PTC) 90%, follicular thyroid cancer (FTC) 10%] …
thyroid cancer (TC)[papillary thyroid cancer (PTC) 90%, follicular thyroid cancer (FTC) 10%] …
Standard and emerging therapeutic approaches for thyroid malignancies
RL Brown - Seminars in oncology, 2008 - Elsevier
Differentiated thyroid cancer (DTC) is the most common endocrine malignancy. The
standard treatment for DTC includes surgery, radioiodine ablation, and thyroid hormone …
standard treatment for DTC includes surgery, radioiodine ablation, and thyroid hormone …
Advancements in the treatment of differentiated thyroid cancer
LA Stewart, JH Kuo - Therapeutic Advances in …, 2021 - journals.sagepub.com
Derived from follicular epithelial cells, differentiated thyroid cancer (DTC) accounts for the
majority of thyroid malignancies. The threefold increase in DTC incidence over the last three …
majority of thyroid malignancies. The threefold increase in DTC incidence over the last three …
[PDF][PDF] New therapeutic advances in the management of progressive thyroid cancer
JA Woyach, MH Shah - Endocrine-related cancer, 2009 - Citeseer
The spectrum of thyroid cancers ranges from one of the most indolent to one of the most
aggressive solid tumors identified. Conventional therapies for thyroid cancers are based on …
aggressive solid tumors identified. Conventional therapies for thyroid cancers are based on …
Differentiated thyroid cancers: a comprehensive review of novel targeted therapies
KL Kojic, SL Kojic, SM Wiseman - Expert review of anticancer …, 2012 - Taylor & Francis
Differentiated thyroid carcinoma (DTC) accounts for more than 90% of new thyroid cancer
diagnoses, and includes papillary, follicular and Hürthle cell carcinoma. The prognosis for …
diagnoses, and includes papillary, follicular and Hürthle cell carcinoma. The prognosis for …
Thyroid cancer: emerging role for targeted therapies
JA Sipos, MH Shah - Therapeutic advances in medical …, 2010 - journals.sagepub.com
The histology and clinical behavior of thyroid cancer are highly diverse. Although most are
indolent tumors with a very favorable outcome with the current standard of care therapy, a …
indolent tumors with a very favorable outcome with the current standard of care therapy, a …
Evolving approaches to patients with advanced differentiated thyroid cancer
BR Haugen, SI Sherman - Endocrine reviews, 2013 - academic.oup.com
Advanced differentiated thyroid cancer (DTC), defined by clinical characteristics including
gross extrathyroidal invasion, distant metastases, radioiodine (RAI) resistance, and avidity …
gross extrathyroidal invasion, distant metastases, radioiodine (RAI) resistance, and avidity …